Your trusted source for investing success


Get our expert guide to Life Science investing FREE!

  Download this FREE Special Report, Life Science Investing Primer – Finding More Opportunities like Medtronic, Ariad Pharmaceuticals and Pharmacyte.

Woulfe Shareholders Approve Business Combination with Almonty

Almonty Industries (TSXV:AII) and Woulfe Mining (CSE:WOF) announced that the Woulfe shareholders have voted in favor of the plan of arrangement that will see the two companies combine. The arrangement will see Almonty acquire all of Woulfe’s outstanding common shares that Almonty does not already own by way of a

Almonty Industries to Acquire Woulfe Mining

Almonty Industries Inc. (TSXV:AII) announced that it has entered into an arrangement agreement with Woulfe Mining Corp. (CSE:WOF) that will see Almonty acquire all of Woulfe’s outstanding shares by way of a court approved plan of arrangement.

Almonty Industries Enters LOI to Acquire Woulfe Mining

Almonty Industries (TSXV:AII) and Woulfe Mining (CSE:WOF) have entered a non-binding letter of intent to combine the two companies and create the leading tungsten producer outside of China. Under the terms of the merger, Almonty would purchase all outstanding shares of Woulfe at a price of $0.08 per share.

Almonty Industries Restates Tungsten Recovery Rates

Almonty Industries Inc. (TSXV:AII) announced the restatement of its tungsten recovery rate for the year ended September 30, 2013 and for the three month interim periods ended June 30, 2013 and March 31, 2013. A faulty calibration of the Company’s on-site lab in March 2013 affected the Company’s assay work


There is no guide to critical metals investing that is more concise, clear and authoritative.

 Download this FREE Special Report, Investing in Today’s Critical Metals – Context for Lynas News and Molycorp News.
Enter Your Log In Credentials
Investing News Network